Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
A new American ****head enters the arena.
https://shorttracker.co.uk/company/GB00BJL5BR07/
Tango28, you've lost all credibility. Just some short position loser pushing negative sentiment.
Tango28, read this:
https://www.lse.co.uk/rns/BIDS/16310m-fundraise-by-way-of-an-accelerated-bookbuild-v8tpx30glgeyeea.html
Markets are broken. Even on good news, shorters aren't allowing NASDAQ share prices to rise.
Another microbiome company published great results today in treating psoriasis:
https://ir.evelobio.com/news-releases/news-release-details/evelo-biosciences-announces-positive-phase-2-clinical-data
What a toxic board, f yourself.
I'm not one of those subtle derampers.
Just bought in on the product which I like. Still pondering whether to invest further, BOD sadly reminds me of my experience owning 7 Digital shares.
Bought a small holding here in the last week.
Been doing some DD over the weekend. Is anyone shocked by how much the directors are paying themselves while the company is making such a large loss? It's got my blood boiling a bit.
Interesting. Does anyone know how many strains there are of a particular species?
I've always wondered how often MRx0518 might appear in donor samples from around the world.
Yeah, there's a few microbiome companies that seem to have very inflated market caps. Evelo, Kaleido and Finch are now the worst offenders after Seres and Forte crashed.
The Seres price looks reasonable now considering it has good cash and a huge down payment from Nestle for the c-diff product that they hope to commercialise soon. Cathie Wood has been selling out at a huge loss this week.
To be honest, I was just wondering if he's going to sell out of 4D to try and recoup any losses. One of his other holdings Benitec Biopharma hasn't looked good either.
Definitely something to keep an eye on this afternoon when US markets open.
Noticed Forte Biosciences crashed about 80-85% yesterday, mostly in post-market trading.
From what I read, Steven Oliveira and associates might have held around $20 milliion in shares before the crash.
Somewhat unnerving knowing he is one of 4D's major shareholders.
Okay Sunnyca, let's do the calculation because you're being so arrogant.
According to the RNS:
He previously had 11.67% of 178,984,386 shares in issue = 20,887,477 shares.
He now has 10.98% of 180,300,967 shares in issue = 19,797,046 shares.
So he's sold over 1 million shares by my calculation.
His holding has gone down from 11.67% to 10.98%. Explain how he bought anything.
Uncrossing trade...
WorldQuant upped their short back above the 0.5% threshold but nobody really thought they'd closed it in the first place.
https://shorttracker.co.uk/company/GB00BJL5BR07/
How sad. Sorry to his family.
@Qd22 Yes, they're possibly picking apart the in-built mechanisms for defending against cancer and many other diseases.
Keep an eye on the 4D's cancer trials. If any of the patients get a "complete response" meaning the cancer is undetectable, Big Pharma will have to take notice. If you look at the monotherapy trial MRx0518, bladder cancer had quite a good response and has now been included in the Phase 2b trial which we should hopefully hear about this year.
They already told us that treatment for bladder cancer looks promising in humans:
"Target tumor reductions in Part B patients have been observed as patients reach the first scheduled restaging timepoint (nine weeks). These include the first signals of anti-tumor activity for the combination in bladder cancer, adding to the previously reported activity in RCC and NSCLC in patients in Part A."
It's from this RNS:
https://www.lse.co.uk/rns/DDDD/oncology-program-update-g7aups4fk7x1yqb.html
Very exciting times.